Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 5/23/2025Dizal's DZD6008 Shows Promising Results in EGFR-Mutant NSCLC with Brai...
  • 5/22/2025China Approves Hengrui's Camrelizumab-Famitinib Combo
  • 5/22/2025Hengrui Pharma Raises $1.27B in Hong Kong Listing
  • 5/22/2025InnoVec Secures Series A Funding to Advance AI-Driven Gene Therapy Pla...
  • 5/22/2025NMPA Approves Bayer's Eylea 8 mg for nAMD
  • 5/22/2025China Approves Raynovent's Onradivir for Adult Influenza A Treatment
  • 5/22/2025NMPA Grants Conditional Approval to JacoBio's Glecirasib for KRAS G12C...
  • 5/22/2025CDE Issues the Guideline on Clinical Trials for Alzheimer's Disease Dr...
  • 5/21/2025Accropeutics Reports Phase 2 Psoriasis Success with TYK2/JAK1 Inhibito...
  • 5/21/2025China's Drugstores Decline Amid Boom in Online Healthcare
  • 5/21/2025China Surges Ahead in Oncology Licensing, GlobalData Reports
  • 5/21/2025China Approves InnoCare's Tafasitamab for R/R DLBCL
  • 5/21/2025CRISPR and Sirius Forge Strategic Alliance for Next-Gen siRNA Therapy
  • 5/21/2025CureGene Completes Series B+ Financing to Advance Cardiometabolic and ...
  • 5/20/2025CSPC Pharma's JMT106 Approved for Clinical Trials in China and the U.S...
  • 5/20/2025CDE Seeks Feedback on Draft Guidelines for Designing Clinical Trials I...
  • 5/20/2025CDE Solicits Feedback on Draft Guidelines for Writing Elderly Patient ...
  • 5/20/2025CDE Seeks Comments on Draft Guideline for Age-Friendly Design in Innov...
  • 5/20/2025CDE Solicits Comments on the 94th Batch of Reference Formulations for ...
  • 5/20/2025Innovent's XNW5004 Receives Breakthrough Therapy Designation
  • 5/20/2025CTTQ Initiates Phase 3 Trial of HER2-Targeting Bispecific ADC TQB2102
  • 5/20/20253SBio Advances SSGJ-707 into Phase 3 Trial for NSCLC
  • 5/20/2025ArkBio Announces Positive Phase II Results of AK3280
  • 5/20/2025SparX and Mitsubishi Tanabe Forge Strategic ADC Research Collaboration
  • 5/20/2025BeiGene Advances BTK Degrader BGB-16673 in Head-to-Head Phase 3 Trial
  • 5/20/2025WuXi Bio Transfers Leverkusen Facility to Terumo in €150 Million Deal
  • 5/20/2025JHM Secures Strategic Investment to Advance Synthetic Biology Innovati...
  • 5/20/2025Nuance Reports Positive Top-Line Results from Phase 3 Trial of Ensifen...
  • 5/20/2025Evive Bio Partners with LENIS Farma to Expand Ryzneuta® Distribution ...
  • 5/20/2025Pfizer Enters into $6B Exclusive Licensing Agreement with 3SBio
  • Page:4/51 Total number of articles:1508: [First][<<] [2] [3] [4] [5] [6] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group